Tech

Morgan Stanley backs Lemonade on autonomous-driving upside tied to Tesla

Morgan Stanley upgrades Lemonade (LMND) to overweight and lifts the price target to $85, citing an autonomous-driving upside anchored by its Tesla partnership. The note argues LMND could emerge as a data-driven winner in auto insurance, with upside if autonomous-vehicle underwriting shifts materialize.

📅 March 17, 2026
⏱️ 2 min read
Morgan Stanley backs Lemonade on autonomous-driving upside tied to Tesla

Key Takeaways

  • Morgan Stanley raises LMND to overweight with a $85 price target (from $80), implying roughly 47% upside.
  • Autonomous driving could reshape auto insurance, and LMND has a data-driven edge from its platform and Tesla tie-up.
  • Lemonade's Tesla partnership offers 50% off per mile for Full Self-Driving users, while maintaining underwriting discipline.
  • Morgan Stanley sees first-mover data analytics advantage and potential to expand Lemonade Car exposures, potentially scaling the business 10x.
  • LMND has fallen about 19% year-to-date but is up about 56% over the last 12 months.

People Involved

  • Bob Jian Huang Morgan Stanley Analyst

Entities Involved

  • Lemonade, Inc. (LMND) Insurtech company with auto-insurance tie-in to Tesla
  • Tesla, Inc. (TSLA) Automaker and partner in Lemonade Car program
  • Morgan Stanley Investment bank issuing the upgrade note

MarketMoodz Analysis

What this means for investors: the note frames autonomous driving as a structural shift that could lift auto-insurance economics and position LMND as a beneficiary thanks to its data moat and early access to the Tesla program. The specific promo—50% off per mile for FSD users—is compelling but contingent on broader adoption and underwriting discipline. The upside hinges on real, scalable collaboration beyond the stated program and on LMND’s ability to monetize data at scale.

Historical context and risk: insurtechs have repeatedly preached data-driven moats with mixed results, and AI-enabled underwriting adds both efficiency and risk (model risk, regulatory scrutiny, and mispricing). The Tesla tie-in mirrors past tech-partner strategies where the narrative outpaced firm-backed execution. The claim of a potential 10x scale reflects ambitious upside but rests on multiple, unproven assumptions about geographic rollout and autopilot adoption.

What to watch next: monitor any updates on expanding the Tesla-Lemonade collaboration, track LMND’s underwriting profitability and loss ratios as autopilot-related exposure grows, and compare with peers’ responses to autonomous-driving auto-insurance shifts. Keep an eye on regulator commentary and broader AI-driven insurance models as a sanity check against hype.

Source: Original Article

Get AI-Powered Market Insights

Stay ahead of market-moving events with our real-time analysis and stock ratings.

Start Your Free Trial